Guidelines for the diagnosis of uncomplicated cirrhosis.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Gastroentérologie Clinique et Biologique

• Publication date

  2007-05-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/S0399-8320(07)89420-6PMID 17541342
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization.

  1978influential reference

• Multiparametric renal function assessment in cirrhotic patients shows high prevalence of medically actionable changes in multiple modules

  2024cites this paper
• The effect of anemia on the efficacy and safety of treating chronic hepatitis C infection with direct-acting antivirals in patients with chronic kidney disease

  2020cites this paper
• Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH).

  2019cites this paper
• Enhanced liver fibrosis test using ELISA assay accurately discriminates advanced stage of liver fibrosis as determined by transient elastography fibroscan in treatment naïve chronic HCV patients

  2018cites this paper
• Transient Elastography as Non-Invasive Examination of Hepatic Fibrosis

  2017cites this paper
• Association of Fibro scan Results with Liver Biopsy and Sonography in Major Thalassemia Patients with Hepatitis C

  2016cites this paper
• Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis.

  2016cites this paper
• The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patients

  2015cites this paper
• Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity

  2015cites this paper
• Liver elastography - where are we now?

  2015cites this paper
• Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.

  2014cites this paper
• Virus-Infected Cirrhotic Patients in Treatment-Experienced Hepatitis C Pegylated Interferon during Triple Therapy Effectiveness of Telaprevir , Boceprevir , and Modeling To Estimate the Antiviral Using Pharmacokinetic and Viral Kinetic

  2014cites this paper
• Renal dysfunction associated with telaprevir-containing triple therapy for chronic hepatitis C: is early prediction possible?

  2014cites this paper
• Comparative Study between Fibroscan and Liver Biopsy Results in Chronic HBV Egyptian Patients: A Single Center Pilot Study

  2014cites this paper
• Using Pharmacokinetic and Viral Kinetic Modeling To Estimate the Antiviral Effectiveness of Telaprevir, Boceprevir, and Pegylated Interferon during Triple Therapy in Treatment-Experienced Hepatitis C Virus-Infected Cirrhotic Patients

  2014cites this paper
• Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis C virus and compliance with chelation.

  2013cites this paper
• Discordance between Liver Biopsy and FibroTest in Assessing Liver Fibrosis in Chronic Hepatitis B

  2013cites this paper
• Role of Liver Biopsy in the Era of Direct-Acting Antivirals

  2013cites this paper
• Management of hepatitis C virus infection in heavy drinkers.

  2013cites this paper
• Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

  2013cites this paper
• Elastometría transicional: Medición no invasiva de la fibrosis hepática. Reporte de 1.000 casos en Argentina

  2012cites this paper
• Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C

  2012cites this paper
• Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.

  2012cites this paper
• Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.

  2012cites this paper
• Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: a retrospective repeated liver biopsy analysis.

  2012cites this paper
• Prospective Validation of FibroTest in Comparison with Liver Stiffness for Predicting Liver Fibrosis in Asian Subjects with Chronic Hepatitis B

  2012cites this paper
• Pegylated Interferon-α2A plus Ribavirin for Chronic Hepatitis C in a Real-Life Setting: The Hepatys French Cohort (2003–2007)

  2012cites this paper
• Laboratory Testing for Liver Disease

  2012cites this paper
• Medición no invasiva de la fibrosis hepática: elastografía. Experiencia en 1200 estudios

  2012cites this paper
• Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age

  2011influential citation
• FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program.

  2011cites this paper
• First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy.

  2011cites this paper
• FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus.

  2011cites this paper
• Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B

  2011influential citation
• Prognostic value of liver fibrosis biomarkers: a meta-analysis.

  2011cites this paper
• Systematic Review of the Literature on Comparative Effectiveness of Antiviral Treatments for Chronic Hepatitis B Infection

  2011cites this paper
• FibroSURE TM and FibroScan ® in relation to treatment response in chronic hepatitis C virus

  2011cites this paper
• response in chronic hepatitis C virus

  2011cites this paper
• Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver

  2010cites this paper
• Noninvasive tools to assess liver disease

  2010cites this paper
• Evaluation of FibroTest-ActiTest in children with chronic hepatitis C virus infection.

  2010cites this paper
• Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis: a comparative study.

  2010cites this paper
• Noninvasive tools to assess liver disease

  2010cites this paper
• valuation of FibroTest — ActiTest in children with hronic hepatitis C virus infection valuation du FibroTest — ActiTest chez l ’ enfant porteur chronique u virus de l ’ hépatite

  2010cites this paper
• Prise en charge d'un malade atteint d'hépatopathie virale chronique candidat à une chimiothérapie Management and treatment in patients with an indication of a chemotherapy and with a chronic viral hepatitis

  2010cites this paper
• Prise en charge et surveillance de la cirrhose

  2010cites this paper
• Biomarkers of Liver Injury for Hepatitis Clinical Trials: A Meta-Analysis of Longitudinal Studies

  2010cites this paper
• Validation of Biochemical Markers for the Prediction of Liver Fibrosis and Necroinflammatory Activity in Hemodialysis Patients with Chronic Hepatitis C

  2010cites this paper
• Université Victor Segalen Bordeaux 2

  2010cites this paper
• Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis

  2010cites this paper
• The goal of therapy is to prevent complications and death from chronic viral hepatitis [2,4]. Because of the slow evolution of chronic hepatitis over sev-

  2010cites this paper
• on-invasive evaluation of liver fibrosis by transient lastography and biochemical markers in elderly npatients valuation non invasive de la fibrose hépatique par lastométrie impulsionnelle et marqueurs iologiques chez la personne âgée hospitalisée

  2009cites this paper
• [Non-invasive diagnosis of liver fibrosis: guidelines for the use of biomarkers and FibroScan].

  2009cites this paper
• FibroScan used in street‐based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study

  2009cites this paper
• Changes of non‐invasive markers and FibroScan values during HCV treatment

  2009cites this paper
• Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C

  2009cites this paper
• Appropriate evidence‐based data overviews demonstrate the diagnostic and prognostic performances of FibroTest in patients with chronic hepatitis C

  2009cites this paper
• Special Issue - Surveillance and prevention of hepatitis B and C in France: assessment and prospects.

  2009cites this paper
• The risks of changing the rules for previously validated biomarkers and using the same patients several times. Response letter to Calès et al. Gastroenterol Clin Biol 2008;32:1050-60: "Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests".

  2009cites this paper
• Non-invasive evaluation of liver fibrosis by transient elastography and biochemical markers in elderly inpatients.

  2009cites this paper
• iagnostic non invasif de la fibrose hépatique : odalités pratiques d ’ utilisation des arqueurs sanguins et du FibroScan on-invasive diagnosis of liver fibrosis : guidelines for the use of iomarkers and FibroScan

  2009cites this paper
• Carcinome hépatocellulaire : une incidence croissante, une prise en charge « optimisée »

  2009cites this paper
• [Transient elastography (FibroScan): a new tool in hepatology].

  2009cites this paper
• Évaluation non invasive de la fibrose hépatique

  2009cites this paper
• Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis C.

  2008cites this paper
• DIAGNOSTIC NON-INVASIF DE LA FIBROSE HEPATIQUE MODALITES PRATIQUES D'UTILISATION DES MARQUEURS SANGUINS ET DU FIBROSCAN NON-INVASIVE DIAGNOSIS OF LIVER FIBROSIS GUIDELINES FOR THE USE OF BIOMARKERS AND FIBROSCAN

  2008influential citation
• Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update.

  2008cites this paper
• CALCIFICAZIONI VALVOLARI CARDIACHE ED EPATOPATIA CRONICA HCV CORRELATA. CORRELAZIONE DEL DANNO VALVOLARE CON I LIVELLI DI OSSIDO NITRICO ESPIRATO. FORMULAZIONE DI NUOVE IPOTESI PATOGENETICHE

  2008cites this paper
• Optimized stepwise combination algorithms of non‐invasive liver fibrosis scores including Hepascore in hepatitis C virus patients

  2008cites this paper
• Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests.

  2008cites this paper
• Combining non-invasive methods for assessment of liver fibrosis.

  2008cites this paper
• The predictive value of FIB‐4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases

  2008cites this paper
• Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update

  2008influential citation
• Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study.

  2008cites this paper
• FibroTest-ActiTest as a non-invasive marker of liver fibrosis.

  2008cites this paper
• Predictive value of FIB‐4 versus fibrotest, APRI, FIBROINDEX and FORNS to noninvasively estimate fibrosis in hepatitis C

  2008cites this paper
• valuation and improvement of a reliable diagnosis f cirrhosis by blood tests valuation et amélioration du diagnostic fiable de irrhose par les tests sanguins

  2008cites this paper
• Évaluation non-invasive de la fibrose hépatique au cours de l'hépatite C

  2008cites this paper
• Transient elastography (FibroScan).

  2008cites this paper
• Access to electronic hepatitis C medical files by general practitioners.

  2008cites this paper
• Non-invasive evaluation of liver fibrosis using FibroScan in long-term sustained-virological responder patients after HCV treatment.

  2008cites this paper
• iagnosis of liver fibrosis using FibroScan and other oninvasive methods in patients with emochromatosis: A prospective study iagnostic de la fibrose hépatique par FibroScan et arqueurs sériques au cours de l’hémochromatose : tude prospective

  2008cites this paper
• HEPACOM: multicenter, observational prospective study of outcome and monitoring of HCV positive antiviral-naïve patients managed in the French health care system.

  2007cites this paper
• Pourquoi et comment évaluer la fibrose hépatique en 2007

  2007cites this paper